ACROSCORE: A new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease

Clinical Endocrinology

Volumn 84, Issue 3, 2016, Pages 380-385

  Prencipe, Nunzia ^a   Floriani, Irene ^b   Guaraldi, Federica ^a   Di Giacomo, Stellina V ^a   Cannavo, Salvatore ^c   Arnaldi, Giorgio ^d   Berton, Alessandro ^a   Torri, Valter ^b   Spinello, Maurizio ^e   Arvat, Emanuela ^f   Ghigo, Ezio ^a   Grottoli, Silvia ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e Italy   (Italy)

^f UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ACROSCORE; ADENOMA; ADULT; ARTICLE; CANCER PATIENT; CARPAL TUNNEL SYNDROME; CLINICAL FEATURE; COLORECTAL POLYP; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HYPERHIDROSIS; MAJOR CLINICAL STUDY; MALE; MICROADENOMA; MULTICENTER STUDY; NEUROLOGIC DISEASE ASSESSMENT; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RARE DISEASE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; THYROID HYPERPLASIA; CASE CONTROL STUDY; CLINICAL TRIAL; DIFFERENTIAL DIAGNOSIS; EARLY DIAGNOSIS; ENDOCRINE SYSTEM EXAMINATION; ENDOCRINOLOGY; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY NEOPLASMS; PROCEDURES; REPRODUCIBILITY; STANDARDS; STATISTICAL MODEL;

ACROMEGALY; ADENOMA; ADULT; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, ENDOCRINE; EARLY DIAGNOSIS; ENDOCRINOLOGY; FEMALE; GROWTH HORMONE-SECRETING PITUITARY ADENOMA; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PITUITARY NEOPLASMS; REPRODUCIBILITY OF RESULTS; ROC CURVE;

EID: 84958869028     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12959     Document Type: Article

References (26)

1. Melmed, S., (2009) Acromegaly pathogenesis and treatment. Journal of Clinical Investigation, 119, 3189-3202.
2. Ayuk, J., Clayton, R.N., Holder, G., et al,. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology Metabolism, 89, 1613-1617.
3. Holdaway, I.M., Rajasoorya, R.C., &, Gamble, G.D., (2004) Factors influencing mortality in acromegaly. Journal of Clinical Endocrinology Metabolism, 89, 667-674.
4. Dekker, O.M., Biermasz, N.R., Pereira, A.M., et al,. (2008) Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology Metabolism, 93, 61-67.
5. Molitch, M., (1992) Clinical manifestations of acromegaly. Endocrinology and Metabolism Clinics of North America, 21, 597-614.
6. Freda, P.U., (2000) Advances in the diagnosis of acromegaly. Endocrinologist, 10, 237-244.
7. Nachtigall, L., Delgado, A., Swearingen, B., et al,. (2008) Changing patterns in diagnosis and therapy of acromegaly over two decades. Journal of Clinical Endocrinology Metabolism, 93, 2035-2041.
8. Giustina, A., Barkan, A., Casanueva, F.F., et al,. (2000) Criteria for cure of acromegaly: a consensus statement. Journal of Clinical Endocrinology Metabolism, 85, 526-529.
9. Giustina, A., Chanson, P., Bronstein, M.D., et al,. (2010) A consensus on criteria for cure of acromegaly. Journal of Clinical Endocrinology Metabolism, 95, 3141-3148.
10. Haynes, A.B., Weiser, T.G., Berry, W.R., et al,. (2009) A surgical safety checklist to reduce morbidity and mortality in a global population. New England Journal of Medicine, 360, 491-499.
11. Melmed, S., (2006) Medical progress: acromegaly. New England Journal of Medicine, 355, 2558-2573.
12. Tanaka, S., Fukuda, I., Hizuka, N., et al,. (2010) Gender differences in serum GH and IGF-I levels and the GH response to dynamic tests in patients with acromegaly. Endocrine Journal, 57, 477-483.
13. Siegel, S., Streetz-van der Werf, C., Schott, J.S., et al,. (2013) Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary, 16, 507-514.
14. Melmed, S., (2001) Acromegaly and cancer: not a problem? Journal of Clinical Endocrinology Metabolism, 86, 2929-2934.
15. Didoni, G., Grottol, S., Gasco, V., et al,. (2004) Cost-of-illness study in acromegalic patients in Italy. Journal of Endocrinological Investigation, 27, 1034-1039.
16. Ben-Shlomo, A., Sheppard, M.C., Stephens, J.M., et al,. (2011) Clinical, quality of life, and economic value of acromegaly disease control. Pituitary, 14, 284-294.
17. Daly, A.F., Rixhon, M., Adam, C., et al,. (2006) High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. Journal of Clinical Endocrinology Metabolism, 91, 4769-4775.
18. Fernandez, A., Karavitaki, N., &, Wass, J.A., (2010) Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clinical Endocrinology (Oxford), 72, 377-382.
19. Cannavò, S., Ferraù, F., Ragonese, M., et al,. (2010) Increased prevalence of acromegaly in a highly polluted area. European Journal of Endocrinology, 163, 509-513.
20. Clemmons, D.R., (2007) IGF-I assays: current assay methodologies and their limitations. Pituitary, 10, 121-128.
21. Clemmons, D.R., (2011) Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clinical Chemistry, 57, 555-559.
22. Clemmons, D.R., (2011) Clinical laboratory indices in the treatment of acromegaly. Clinica Chimica Acta, 412, 403-409.
23. Schneider, H.J., Kosilek, R.P., Günther, M., et al,. (2011) A novel approach to the detection of acromegaly: accuracy of diagnosis by automatic face classification. Journal of Clinical Endocrinology Metabolism, 96, 2074-2080.
24. Miller, R.E., Learned-Miller, E.G., Trainer, P., et al,. (2011) Early diagnosis of acromegaly: computers vs clinicians. Clinical Endocrinology (Oxford), 75, 226-231.
25. Reid, T.J., Post, K.D., Bruce, J.N., et al,. (2010) Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clinical Endocrinology (Oxford), 72, 203-208.
26. Collini, P., Beadsworth, M., Anson, J., et al,. (2007) Community-acquired pneumonia: doctors do not follow national guidelines. Postgraduate Medical Journal, 83, 552-555.